Onconetix Inc (ONCO)

Apr 03, 2025

Onconetix Names Interim CFO Karina Fedasz as Interim CEO - MarketWatch

Apr 03, 2025

Apr 03, 2025

Onconetix Appoints Karina Fedasz as Interim CEO - TipRanks

Apr 03, 2025

Apr 01, 2025

Onconetix Delays Yearly Report Filing - TipRanks

Apr 01, 2025

Mar 27, 2025

Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews

Mar 27, 2025

Mar 25, 2025

Onconetix claims validation of prostate cancer test Proclarix in Danish cohort - Yahoo Finance

Mar 25, 2025

Mar 25, 2025

Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort - GlobeNewswire

Mar 25, 2025

Mar 24, 2025

Onconetix reveals Proclarix’s clinical performance at EAU congress - Investing.com India

Mar 24, 2025

Mar 24, 2025

Onconetix Announces Successful Clinical Validation Of Proclarix For Prostate Cancer In Danish Cohort - Nasdaq

Mar 24, 2025

Mar 24, 2025

Onconetix reveals Proclarix’s clinical performance at EAU congress By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Onconetix Inc. Presents Promising Clinical Data for Proclarix® at 2025 EAU Congress - Nasdaq

Mar 24, 2025

Mar 24, 2025

Revolutionary Prostate Cancer Test Cuts Unnecessary Biopsies by 22%, Shows 96% Detection Rate - Stock Titan

Mar 24, 2025

Mar 21, 2025

Onconetix Inc (NASDAQ: ONCO): Blank Check On Growth? - Stocks Register

Mar 21, 2025

Mar 19, 2025

Onconetix Announces New Clinical Data for its Innovative - GlobeNewswire

Mar 19, 2025

Mar 19, 2025

Onconetix to Present Proclarix at EAU Congress 2025 - TipRanks

Mar 19, 2025

Mar 19, 2025

Onconetix, Inc. to Present Proclarix Study Results at 2025 EAU Congress in Madrid - Nasdaq

Mar 19, 2025

Mar 19, 2025

Groundbreaking 800-Patient Study Shows How Onconetix's Proclarix Test Prevents Unnecessary Prostate Biopsies - StockTitan

Mar 19, 2025

Mar 19, 2025

ONCO stock plunges to 52-week low, touches $0.12 By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

ONCO stock plunges to 52-week low, touches $0.12 - Investing.com India

Mar 18, 2025

Mar 03, 2025

Onconetix taps industry veteran as executive chairman amid CEO resignation - The Business Journals

Mar 03, 2025

Feb 28, 2025

Onconetix names new executive chairman, appoints board member By Investing.com - Investing.com Australia

Feb 28, 2025

Feb 28, 2025

Onconetix names new executive chairman, appoints board member - Investing.com India

Feb 28, 2025

Feb 28, 2025

Onconetix Announces Leadership Changes and New Appointments - TipRanks

Feb 28, 2025

Feb 28, 2025

Onconetix Says Ralph Schiess Resigns As Interim CEO And Chief Science Officer -February 28, 2025 at 05:35 pm EST - Marketscreener.com

Feb 28, 2025

Feb 19, 2025

Onconetix secures new financing, appoints auditor, sees executive exit By Investing.com - Investing.com South Africa

Feb 19, 2025

Feb 18, 2025

Onconetix secures new financing, appoints auditor, sees executive exit - Investing.com

Feb 18, 2025

Feb 18, 2025

Onconetix Announces Promissory Note Agreement with Keystone - TipRanks

Feb 18, 2025

Feb 05, 2025

Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

Feb 05, 2025

Feb 04, 2025

Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle

Feb 04, 2025

Feb 04, 2025

Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex

Feb 04, 2025

Jan 29, 2025

Onconetix files to sell 50M shares of common stock for holders - MSN

Jan 29, 2025

Jan 27, 2025

Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn

Jan 27, 2025

Jan 27, 2025

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 27, 2025

Jan 26, 2025

Onconetix faces Nasdaq delisting over share price rule - MSN

Jan 26, 2025

Jan 24, 2025

Onconetix faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria

Jan 24, 2025

Jan 23, 2025

Onconetix settles with IQVIA, adjusts accounts payable - MSN

Jan 23, 2025

Jan 22, 2025

Onconetix settles with IQVIA, adjusts accounts payable By Investing.com - Investing.com Canada

Jan 22, 2025

Jan 12, 2025

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Jan 12, 2025

Jan 03, 2025

Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews

Jan 03, 2025

Dec 31, 2024

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga

Dec 31, 2024

Dec 19, 2024

ONCO Stock Plummets to 52-Week Low at $0.37 Amid Market Struggles By Investing.com - Investing.com South Africa

Dec 19, 2024

Dec 13, 2024

Onconetix files overdue quarterly report, addresses Nasdaq notice By Investing.com - Investing.com South Africa

Dec 13, 2024

Dec 12, 2024

Onconetix files overdue quarterly report, addresses Nasdaq notice - Investing.com

Dec 12, 2024

Dec 12, 2024

Onconetix, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire

Dec 12, 2024

Dec 12, 2024

Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - StockTitan

Dec 12, 2024

Dec 11, 2024

ONCO stock touches 52-week low at $0.58 amid market challenges - Investing.com India

Dec 11, 2024

Dec 10, 2024

Onconetix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 10, 2024

Dec 10, 2024

Onconetix Inc. (ONCO) reports earnings - Quartz

Dec 10, 2024

Dec 03, 2024

Onconetix amends forbearance agreement with Veru Inc. - Investing.com

Dec 03, 2024